Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy

Jan 20, 2022

CytoDyn reveals results for cancer and NASH patients

Nov 5, 2021

CCR5 closes the 1 temporal window for memory linking

Nov 1, 2021

FDA accepts revised rolling review timeline for resubmission of its BLA

Oct 29, 2021

CytoDyn to Hold Webcast and Live Q/A on October 26

Oct 26, 2021

CytoDyn looks forward to 2021 Annual Meeting of Stockholders on October 28

Oct 21, 2021

Recent Progress and Expectations in Oncology, COVID-19, and other Programs

Oct 14, 2021

Brazil has approved critically ill COVID Phase 3 to begin

Sep 22, 2021

CytoDyn presents to large gathering of medical staff in different hospitals in Philippines

Sep 19, 2021

Leronlimab COVID-19 Brazil Trial enrolled the first patient

Sep 10, 2021

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• ...16
• Next »